TriSalus Life Sciences, Inc. (TLSI) Discusses Pressure-Enabled Drug Delivery and Advances in Uterine Fibroid Embolization Transcript
Source: SeekingAlpha
2025-11-12 16:21:33 ET
TriSalus Life Sciences, Inc. (TLSI) Discusses Pressure-Enabled Drug Delivery and Advances in Uterine Fibroid Embolization November 12, 2025 10:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
TriSalus Life Sciences, Inc. (TLSI) Discusses Pressure-Enabled Drug Delivery and Advances in Uterine Fibroid Embolization Transcript
TriSalus Life Sciences Inc. Warrant
NASDAQ: TLSIW
TLSIW Trading
-1.27% G/L:
$1.56 Last:
1,306 Volume:
$1.58 Open:
TLSIW Latest News
TLSIW Stock Data
$218,310,730
36,224,125
N/A
18
N/A
Medical Equipment & Supplies
Healthcare
US
Westminster
